feedback

Course Director

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC

Adult Hematology Nurse Practitioner
Temple/Fox Chase Cancer Center
Philadelphia, Pennsylvania

Faculty

Beth Faiman
Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN

Nurse Practitioner, Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Lisa Nodzon
Lisa Nodzon, PhD, ARNP, AOCNP

Advanced Registered Nurse Practitioner Moffitt Cancer Center & Research Institute Tampa, Florida

Accredited by

Penn State College of Medicine / Medical Learning Institute, Inc.

Activity Details

Credit Types:CME / CNE
Credit Amount:1.5 Credits
Release Date:2019-May-22
Expiration Date:2020-May-21
Estimated Time for Completion:1.5 hours
Registration Required:No
Cost:Free of Charge

Activity Description and Educational Objectives

Recent developments in B-cell lymphoma have increased the availability of novel, orally administered therapies. Nurse professionals managing patients with B-cell cancers play a central role in caring for patients who are eligible for treatment with oral therapeutics, including BTK, PI3K, and BCL-2 inhibitors, and immunomodulating agents. In this activity, based on a recent live symposium held at the ONS 44th Annual Congress, an expert nurse faculty panel offers an in-depth look at the integration of novel, orally administered therapies in the B-cell cancer setting and the therapeutic applications of these agents, as well as the practical issues that are central to oncology nursing practice.

Upon completion of this activity, participants will be able to:
  • Cite updated evidence about the use of novel, orally administered agent classes in B-cell cancers, including BTK, PI3K, and BCL-2 inhibitors, immunomodulators, and other oral therapies
  • Develop treatment plans in consultation with a wider oncology management team for patients with B-cell lymphoma who are candidates for oral therapies
  • Educate patients about practical issues surrounding the use of oral therapies for CLL, MCL, and FL, including adherence, safety, and therapeutic expectations
  • Manage dosing, adherence, and safety considerations in patients with B-cell lymphoma receiving oral agents as part of their therapy

Target Audience

This activity has been designed to meet the educational needs of oncology nurses and other clinicians involved in the management of patients with lymphoma.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 80% or higher is needed to obtain CME credit and 70% or higher to obtain CNE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: May 22, 2019 - May 21, 2020
Time to Complete: 90 minutes

Faculty and Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Penn State College of Medicine and Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Course Director and Moderator

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
Adult Hematology Nurse Practitioner
Temple/Fox Chase Cancer Center
Philadelphia, Pennsylvania

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Cardinal Health; Genentech, Inc.; and Mylan, Inc.
Speakers Bureau participant with AbbVie Inc.; Genentech, Inc.; and Seattle Genetics, Inc.

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: ibrutinib and acalabrutinib.

Faculty

Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN
Nurse Practitioner, Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Amgen; Bristol-Myers Squibb; Celgene Corporation; Janssen Pharmaceuticals, Inc.; and Takeda Pharmaceutical Company.
Speakers Bureau participant with Amgen; Bristol-Myers Squibb; Celgene Corporation; Janssen Pharmaceuticals, Inc.; and Takeda Pharmaceutical Company.

Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: lenalidomide.

Lisa Nodzon, PhD, ARNP, AOCNP
Advanced Registered Nurse Practitioner
Moffitt Cancer Center & Research Institute
Tampa, Florida

Lisa Nodzon , PhD, ARNP, AOCNP, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AbbVie Inc.; Genentech, Inc.; Gilead; and Janssen Pharmaceuticals, Inc.
Speakers Bureau participant with AbbVie Inc.; Genentech, Inc.; and Gilead.

Lisa Nodzon , PhD, ARNP, AOCNP, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: venetoclax and ibrutinib.

Content Reviewers

Tracy L. Greene, MSN, RN, FNP-C, Lead Nurse Planner, has no financial interests/relationships or affiliations in relation to this activity.

Janice Trainor-Tellier, MSN, RN, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca has no financial interests/relationships or affiliations in relation to this activity.

Other PVI associates who are in a position to have control over the content of this activity, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CNE activity during the past 12 months.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

The associates of the Medical Learning Institute, Inc., the accredited CNE provider for this activity, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CNE activity during the past 12 months.

Disclaimer

The information provided at this CME/CNE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit, and Support

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G6458-19-T.

Nurses

Medical Learning Institute, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Successful completion of this continuing nursing education activity will be awarded 1.5 contact hour(s).

Providership


This CME/CNE activity is jointly provided by Penn State College of Medicine and PVI, PeerView Institute for Medical Education; this activity is also co-provided by Medical Learning Institute, Inc.

Support

This activity is supported by educational grants from Celgene Corporation, Gilead Sciences, Inc., and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME/CNE Activity

PVI, PeerView Institute for Medical Education, Penn State College of Medicine, and Medical Learning Institute, Inc. are responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this activity. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI, Penn State College of Medicine, and Medical Learning Institute, Inc. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. For approved prescribing information, please consult the manufacturer's product labeling. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our activities. No responsibility is taken for errors or omissions in activities.

Copyright © 2000-2019, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.